Gastrointestinal cancers represent a field undergoing rapid and profound transformation, characterized by marked biological and clinical heterogeneity and a significant impact in terms of incidence, mortality, and management complexity. The aim of the event is to provide a critical and integrated update on the most recent scientific evidence, promoting a cross-disciplinary interpretation of available data and supporting clinicians in translating innovations into clinical practice.